FDA: Eisai ‘s “Rembima” approved as a hepatocellular cancer drug Saturday August 18th, 2018By Tokio X'press Cancer, FDA, Pharmaceutical
Woman sues Kellogg after developing sepsis Friday June 22nd, 2018By Tokio X'press FDA, Recall Woman sues Kellogg
💊Otsuka’s JYNARQUE™ Approved by U.S. FDA as the First Treatment to Slow Kidney Function Decline in Adults at Risk of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease (ADPKD) Wednesday April 25th, 2018By Tokio X'press FDA, Pharmaceutical otsuka
⛔200M eggs recalled because of salmonella concerns Monday April 16th, 2018By Tokio X'press Accident, FDA salmonella
💊Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Penta-Refractory Multiple Myeloma Thursday April 12th, 2018By Tokio X'press FDA, Pharmaceutical ONO